The Platelia SARS-CoV-2 Total Ab assay ensures reliable and fully automated detection of anti-SARS-CoV-2 IgM, IgA and IgG in one test to determine the immune response to SARS-CoV-2.
- High specificity (99.56%)
- Excellent sensitivity (97.5%) on patients tested >8 days after onset of symptoms, allows for reliable detection of COVID-19 cases
- 1-step antigen capture format (only 90 min incubation time required)
- Visual control of sample dilution and reagent addition
The Platelia SARS-CoV-2 Total Ab assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy Platelia SARS-CoV-2 Total Ab assay for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Platelia SARS-CoV-2 Total Ab assay or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Platelia SARS-CoV-2 Total Ab assay or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
